Idarucizumab
Modify Date: 2024-01-01 23:33:51
Idarucizumab structure
|
Common Name | Idarucizumab | ||
|---|---|---|---|---|
| CAS Number | 1362509-93-0 | Molecular Weight | N/A | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | N/A | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of IdarucizumabIdarucizumab is a humanized monoclonal antibody fragment. Idarucizumab is first reversal agent for a direct oral anticoagulant (DOAC). Idarucizumab can specifically neutralize the effects of the oral direct thrombin inhibitor in order to restore hemostasis[1]. |
| Name | Idarucizumab |
|---|
| Description | Idarucizumab is a humanized monoclonal antibody fragment. Idarucizumab is first reversal agent for a direct oral anticoagulant (DOAC). Idarucizumab can specifically neutralize the effects of the oral direct thrombin inhibitor in order to restore hemostasis[1]. |
|---|---|
| Related Catalog | |
| References |
| No Any Chemical & Physical Properties |